8Common Ltd
8CO8Common Ltd's reference price fell 14.29% from A$0.035 on 2026-10-09 to A$0.03 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
8Common Ltd's reference price fell 14.29% from A$0.035 on 2026-10-09 to A$0.03 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Actinogen Medical Limited
ACWActinogen Medical Limited's reference price fell 7.27% from A$0.055 on 2026-10-09 to A$0.051 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Actinogen Medical Limited's reference price fell 7.27% from A$0.055 on 2026-10-09 to A$0.051 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
AdNeo Limited
AD1AdNeo Limited's reference price rose 16.67% from A$0.012 on 2026-10-09 to A$0.014 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
AdNeo Limited's reference price rose 16.67% from A$0.012 on 2026-10-09 to A$0.014 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Adherium Ltd.
ADRAdherium Ltd.'s reference price fell 9.09% from A$0.077 on 2026-10-09 to A$0.07 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Adherium Ltd.'s reference price fell 9.09% from A$0.077 on 2026-10-09 to A$0.07 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Australian Gold & Copper Ltd.
AGCAustralian Gold & Copper Ltd.'s reference price rose 8.33% from A$0.12 on 2026-10-09 to A$0.13 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Australian Gold & Copper Ltd.'s reference price rose 8.33% from A$0.12 on 2026-10-09 to A$0.13 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Advanced Innergy Holdings Ltd.
AIHAdvanced Innergy Holdings Ltd.'s reference price fell 6.02% from A$0.415 on 2026-10-09 to A$0.39 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Advanced Innergy Holdings Ltd.'s reference price fell 6.02% from A$0.415 on 2026-10-09 to A$0.39 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Arovella Therapeutics Limited
ALAArovella Therapeutics Limited's reference price rose 5.77% from A$0.052 on 2026-10-09 to A$0.055 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Arovella Therapeutics Limited's reference price rose 5.77% from A$0.052 on 2026-10-09 to A$0.055 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Altair Minerals limited
ALRAltair Minerals limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Altair Minerals limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Alvo Minerals Limited
ALVAlvo Minerals Limited's reference price rose 7.14% from A$0.07 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Alvo Minerals Limited's reference price rose 7.14% from A$0.07 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Almasar Minerals Limited
AMKAlmasar Minerals Limited's reference price rose 6.98% from A$0.215 on 2026-10-09 to A$0.23 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Almasar Minerals Limited's reference price rose 6.98% from A$0.215 on 2026-10-09 to A$0.23 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Agrimin Limited
AMNAgrimin Limited's reference price fell 8.16% from A$0.049 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Agrimin Limited's reference price fell 8.16% from A$0.049 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Ashley Services Group Ltd.
ASHAshley Services Group Ltd.'s reference price fell 5.08% from A$0.295 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Ashley Services Group Ltd.'s reference price fell 5.08% from A$0.295 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Augustus Minerals Limited
AUGAugustus Minerals Limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Augustus Minerals Limited's reference price fell 5.00% from A$0.04 on 2026-10-09 to A$0.038 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Avada Group Limited
AVDAvada Group Limited's reference price fell 5.56% from A$0.09 on 2026-10-09 to A$0.085 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Avada Group Limited's reference price fell 5.56% from A$0.09 on 2026-10-09 to A$0.085 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Advance Metals Limited
AVMAdvance Metals Limited's reference price rose 7.14% from A$0.042 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Advance Metals Limited's reference price rose 7.14% from A$0.042 on 2026-10-09 to A$0.045 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Axiant Resources Limited
AXRAxiant Resources Limited's reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Axiant Resources Limited's reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Bridge Saas Limited
BGEBridge Saas Limited's reference price fell 12.50% from A$0.008 on 2026-10-09 to A$0.007 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Bridge Saas Limited's reference price fell 12.50% from A$0.008 on 2026-10-09 to A$0.007 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Ballard Mining Limited
BM1Ballard Mining Limited's reference price fell 9.09% from A$0.715 on 2026-10-09 to A$0.65 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Ballard Mining Limited's reference price fell 9.09% from A$0.715 on 2026-10-09 to A$0.65 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Baumart Holdings Ltd
BMHBaumart Holdings Ltd's reference price rose 18.18% from A$0.011 on 2026-10-09 to A$0.013 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Baumart Holdings Ltd's reference price rose 18.18% from A$0.011 on 2026-10-09 to A$0.013 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Ballymore Resources Limited
BMRBallymore Resources Limited's reference price fell 6.15% from A$0.13 on 2026-10-09 to A$0.122 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Ballymore Resources Limited's reference price fell 6.15% from A$0.13 on 2026-10-09 to A$0.122 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Credit Clear Limited
CCRCredit Clear Limited's reference price fell 7.41% from A$0.135 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Credit Clear Limited's reference price fell 7.41% from A$0.135 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Challenger Gold Limited
CELChallenger Gold Limited's reference price fell 5.10% from A$1.57 on 2026-10-09 to A$1.49 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Challenger Gold Limited's reference price fell 5.10% from A$1.57 on 2026-10-09 to A$1.49 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Cogstate Ltd
CGSCogstate Ltd's reference price rose 10.14% from A$3.45 on 2026-10-09 to A$3.8 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Cogstate Ltd's reference price rose 10.14% from A$3.45 on 2026-10-09 to A$3.8 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Carma Limited
CMACarma Limited's reference price rose 7.25% from A$0.69 on 2026-10-09 to A$0.74 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Carma Limited's reference price rose 7.25% from A$0.69 on 2026-10-09 to A$0.74 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Critical Minerals Group Ltd.
CMGCritical Minerals Group Ltd.'s reference price rose 6.78% from A$0.059 on 2026-10-09 to A$0.063 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Critical Minerals Group Ltd.'s reference price rose 6.78% from A$0.059 on 2026-10-09 to A$0.063 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Cosol Limited
COSCosol Limited's reference price fell 9.52% from A$0.21 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Cosol Limited's reference price fell 9.52% from A$0.21 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Cooper Metals Limited
CPMCooper Metals Limited's reference price fell 19.35% from A$0.093 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Cooper Metals Limited's reference price fell 19.35% from A$0.093 on 2026-10-09 to A$0.075 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Cue Energy Resources Limited
CUECue Energy Resources Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Cue Energy Resources Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Caravel Minerals Limited
CVVCaravel Minerals Limited's reference price fell 11.32% from A$0.265 on 2026-10-09 to A$0.235 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Caravel Minerals Limited's reference price fell 11.32% from A$0.265 on 2026-10-09 to A$0.235 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
CYP.AX (issuer name unverified)
CYP.AXAn unconfirmed report for CYP.AX (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for CYP.AX (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Corazon Mining Limited
CZNCorazon Mining Limited's reference price fell 9.09% from A$0.11 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Corazon Mining Limited's reference price fell 9.09% from A$0.11 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
CZR Resources Ltd
CZRCZR Resources Ltd's reference price rose 5.13% from A$0.195 on 2026-10-09 to A$0.205 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
CZR Resources Ltd's reference price rose 5.13% from A$0.195 on 2026-10-09 to A$0.205 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
De.mem Ltd.
DEMDe.mem Ltd.'s reference price rose 13.64% from A$0.11 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
De.mem Ltd.'s reference price rose 13.64% from A$0.11 on 2026-10-09 to A$0.125 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
E79 Gold Mines Limited
E79E79 Gold Mines Limited's reference price rose 10.71% from A$0.028 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
E79 Gold Mines Limited's reference price rose 10.71% from A$0.028 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Enero Group Limited
EGGEnero Group Limited's reference price fell 6.38% from A$0.235 on 2026-10-09 to A$0.22 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Enero Group Limited's reference price fell 6.38% from A$0.235 on 2026-10-09 to A$0.22 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Environmental Group Limited
EGLEnvironmental Group Limited's reference price rose 10.61% from A$0.066 on 2026-10-09 to A$0.073 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Environmental Group Limited's reference price rose 10.61% from A$0.066 on 2026-10-09 to A$0.073 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Eagle Mountain Mining Ltd.
EM2Eagle Mountain Mining Ltd.'s reference price rose 20.00% from A$0.005 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Eagle Mountain Mining Ltd.'s reference price rose 20.00% from A$0.005 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Emyria Ltd
EMDEmyria Ltd's reference price fell 7.14% from A$0.042 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Emyria Ltd's reference price fell 7.14% from A$0.042 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Encounter Resources Limited
ENREncounter Resources Limited's reference price rose 9.80% from A$0.255 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Encounter Resources Limited's reference price rose 9.80% from A$0.255 on 2026-10-09 to A$0.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Enova Mining Limited
ENVEnova Mining Limited's reference price fell 20.00% from A$0.0025 on 2026-10-09 to A$0.002 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Enova Mining Limited's reference price fell 20.00% from A$0.0025 on 2026-10-09 to A$0.002 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Eclipse Metals Limited
EPMEclipse Metals Limited's reference price fell 8.33% from A$0.012 on 2026-10-09 to A$0.011 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Eclipse Metals Limited's reference price fell 8.33% from A$0.012 on 2026-10-09 to A$0.011 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Firebrick Pharma Limited
FREFirebrick Pharma Limited's reference price rose 6.90% from A$0.029 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Firebrick Pharma Limited's reference price rose 6.90% from A$0.029 on 2026-10-09 to A$0.031 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Golden Mile Resources Ltd.
G88Golden Mile Resources Ltd.'s reference price fell 9.09% from A$0.0055 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Golden Mile Resources Ltd.'s reference price fell 9.09% from A$0.0055 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Globe Metals & Mining Limited
GBEGlobe Metals & Mining Limited's reference price fell 5.45% from A$0.055 on 2026-10-09 to A$0.052 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Globe Metals & Mining Limited's reference price fell 5.45% from A$0.055 on 2026-10-09 to A$0.052 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Great Boulder Resources Ltd
GBRGreat Boulder Resources Ltd's reference price rose 6.38% from A$0.094 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Great Boulder Resources Ltd's reference price rose 6.38% from A$0.094 on 2026-10-09 to A$0.1 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Galan Lithium Limited
GLNGalan Lithium Limited's reference price fell 9.26% from A$0.27 on 2026-10-09 to A$0.245 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Galan Lithium Limited's reference price fell 9.26% from A$0.27 on 2026-10-09 to A$0.245 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Great Western Exploration Limited
GTEGreat Western Exploration Limited's reference price rose 12.50% from A$0.008 on 2026-10-09 to A$0.009 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Great Western Exploration Limited's reference price rose 12.50% from A$0.008 on 2026-10-09 to A$0.009 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
H3 Energy Limited
H3EH3 Energy Limited's reference price rose 11.11% from A$0.0045 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
H3 Energy Limited's reference price rose 11.11% from A$0.0045 on 2026-10-09 to A$0.005 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
HeraMED Ltd
HMDHeraMED Ltd's reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
HeraMED Ltd's reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Hamelin Gold Limited
HMGHamelin Gold Limited's reference price fell 11.11% from A$0.225 on 2026-10-09 to A$0.2 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Hamelin Gold Limited's reference price fell 11.11% from A$0.225 on 2026-10-09 to A$0.2 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Harris Technology Group Limited
HT8Harris Technology Group Limited's reference price rose 6.67% from A$0.015 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Harris Technology Group Limited's reference price rose 6.67% from A$0.015 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Iceni Gold Ltd.
ICLIceni Gold Ltd.'s reference price fell 5.56% from A$0.018 on 2026-10-09 to A$0.017 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Iceni Gold Ltd.'s reference price fell 5.56% from A$0.018 on 2026-10-09 to A$0.017 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Infocus Group Holdings Limited
IFGInfocus Group Holdings Limited's reference price fell 11.11% from A$0.009 on 2026-10-09 to A$0.008 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Infocus Group Holdings Limited's reference price fell 11.11% from A$0.009 on 2026-10-09 to A$0.008 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
ikeGPS Group Ltd
IKEikeGPS Group Ltd's reference price fell 5.56% from A$0.9 on 2026-10-09 to A$0.85 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
ikeGPS Group Ltd's reference price fell 5.56% from A$0.9 on 2026-10-09 to A$0.85 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Jameson Resources Limited
JALJameson Resources Limited's reference price rose 5.88% from A$0.034 on 2026-10-09 to A$0.036 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Jameson Resources Limited's reference price rose 5.88% from A$0.034 on 2026-10-09 to A$0.036 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Jade Gas Holdings Limited
JGHJade Gas Holdings Limited's reference price fell 5.80% from A$0.069 on 2026-10-09 to A$0.065 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Jade Gas Holdings Limited's reference price fell 5.80% from A$0.069 on 2026-10-09 to A$0.065 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Kaoko Metals Ltd
KAOKaoko is a pre-revenue Namibian copper-silver explorer whose first two holes show positive grades despite a large reported share decline. Further assays, true widths and continuity are catalysts; no resource, metallurgy or mine economics yet support value, and price sources conflict.
More details
Investment thesis
Kaoko is a pre-revenue Namibian copper-silver explorer whose first two holes show positive grades despite a large reported share decline. Further assays, true widths and continuity are catalysts; no resource, metallurgy or mine economics yet support value, and price sources conflict.
Risk / thesis breaker
['unsupported FY1/FY2 and matched peers', 'official adjusted CSPA not verified', 'current gross capital/cash and exact account permission unresolved']
Kip McGrath Education Centres Limited
KMETutoring provider with an unconditional A$0.75 cash offer closing October19. At indicative A$0.69, a new ex-dividend buyer might receive1.087x cash, but the deed and entitlement footnote disagree on whether six cents is deducted. Payment interpretation, funding and minority illiquidity are the main breakers.
More details
Investment thesis
Tutoring provider with an unconditional A$0.75 cash offer closing October19. At indicative A$0.69, a new ex-dividend buyer might receive1.087x cash, but the deed and entitlement footnote disagree on whether six cents is deducted. Payment interpretation, funding and minority illiquidity are the main breakers.
Risk / thesis breaker
Dividend/rights treatment; bidder funding/payment delay; acceptance mechanics; minority illiquidity; incomplete audits
Kingston Resources Ltd.
KSNKingston Resources Ltd.'s reference price fell 5.71% from A$0.035 on 2026-10-09 to A$0.033 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Kingston Resources Ltd.'s reference price fell 5.71% from A$0.035 on 2026-10-09 to A$0.033 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Little Green Pharma Ltd.
LGPLittle Green Pharma Ltd.'s reference price rose 7.81% from A$0.064 on 2026-10-09 to A$0.069 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Little Green Pharma Ltd.'s reference price rose 7.81% from A$0.064 on 2026-10-09 to A$0.069 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Lifestyle Communities Ltd
LICLifestyle Communities Ltd's reference price fell 9.72% from A$4.22 on 2026-10-09 to A$3.81 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Lifestyle Communities Ltd's reference price fell 9.72% from A$4.22 on 2026-10-09 to A$3.81 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
MB Gold Limited
MBGMB Gold Limited's reference price fell 7.32% from A$0.205 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
MB Gold Limited's reference price fell 7.32% from A$0.205 on 2026-10-09 to A$0.19 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Metro Mining Limited
MMIMetro Mining Limited's reference price fell 25.42% from A$1.18 on 2026-10-09 to A$0.88 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Metro Mining Limited's reference price fell 25.42% from A$1.18 on 2026-10-09 to A$0.88 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Macallum New Energy Limited
MNEMacallum New Energy Limited's reference price fell 5.71% from A$0.175 on 2026-10-09 to A$0.165 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Macallum New Energy Limited's reference price fell 5.71% from A$0.175 on 2026-10-09 to A$0.165 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Monvia Limited
MNVMonvia Limited's reference price fell 6.80% from A$1.03 on 2026-10-09 to A$0.96 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Monvia Limited's reference price fell 6.80% from A$1.03 on 2026-10-09 to A$0.96 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
MOVe Logistics Group Limited
MOVMOVe Logistics Group Limited's reference price fell 19.44% from A$0.18 on 2026-10-09 to A$0.145 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
MOVe Logistics Group Limited's reference price fell 19.44% from A$0.18 on 2026-10-09 to A$0.145 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
NH3 Clean Energy Limited
NH3NH3 Clean Energy Limited's reference price rose 8.43% from A$0.083 on 2026-10-09 to A$0.09 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
NH3 Clean Energy Limited's reference price rose 8.43% from A$0.083 on 2026-10-09 to A$0.09 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Nimy Resources Limited
NIMNimy Resources Limited's reference price rose 5.41% from A$0.037 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Nimy Resources Limited's reference price rose 5.41% from A$0.037 on 2026-10-09 to A$0.039 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
New Murchison Gold Limited
NMGNew Murchison Gold Limited's reference price fell 6.06% from A$0.066 on 2026-10-09 to A$0.062 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
New Murchison Gold Limited's reference price fell 6.06% from A$0.066 on 2026-10-09 to A$0.062 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Nordic Resources Limited.
NNLNordic Resources Limited.'s reference price rose 5.71% from A$0.175 on 2026-10-09 to A$0.185 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Nordic Resources Limited.'s reference price rose 5.71% from A$0.175 on 2026-10-09 to A$0.185 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
NewPeak Metals Limited
NPMExploration company with less than one quarter of cash runway at the reported burn. A full historical mark liquidation of its LKO holding extends runway only to1.267quarters; saleability, drilling spend and dilutive financing remain the central risks.
More details
Investment thesis
Exploration company with less than one quarter of cash runway at the reported burn. A full historical mark liquidation of its LKO holding extends runway only to1.267quarters; saleability, drilling spend and dilutive financing remain the central risks.
Risk / thesis breaker
Further dilution, uncertain saleability/price/encumbrance of LKO stake, exploration metallurgy/resource/economic uncertainty, broker local-security access unverified.
Nuchev Pty Ltd
NUCNuchev Pty Ltd's reference price fell 5.88% from A$0.085 on 2026-10-09 to A$0.08 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Nuchev Pty Ltd's reference price fell 5.88% from A$0.085 on 2026-10-09 to A$0.08 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Octava Minerals Ltd.
OCTOctava Minerals Ltd.'s reference price fell 9.09% from A$0.022 on 2026-10-09 to A$0.02 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Octava Minerals Ltd.'s reference price fell 9.09% from A$0.022 on 2026-10-09 to A$0.02 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Orcoda Limited
ODAOrcoda Limited's reference price rose 7.27% from A$0.055 on 2026-10-09 to A$0.059 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Orcoda Limited's reference price rose 7.27% from A$0.055 on 2026-10-09 to A$0.059 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
OpenLearning Ltd.
OLLOpenLearning Ltd.'s reference price fell 7.69% from A$0.013 on 2026-10-09 to A$0.012 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
OpenLearning Ltd.'s reference price fell 7.69% from A$0.013 on 2026-10-09 to A$0.012 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
PHX (issuer name unverified)
PHXPHX has a Q1 FY2027 investor-update announcement, but no supported recurring-profit or cash-flow case is established. The operating catalyst, capital needs and valuation are unknown, so weak cash conversion or dilution could invalidate the setup.
More details
Investment thesis
PHX has a Q1 FY2027 investor-update announcement, but no supported recurring-profit or cash-flow case is established. The operating catalyst, capital needs and valuation are unknown, so weak cash conversion or dilution could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Peak Processing Limited
PKPPeak Processing Limited's reference price fell 5.88% from A$0.017 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Peak Processing Limited's reference price fell 5.88% from A$0.017 on 2026-10-09 to A$0.016 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Paterson Resources Limited
PSLPaterson Resources Limited's reference price rose 5.13% from A$0.039 on 2026-10-09 to A$0.041 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Paterson Resources Limited's reference price rose 5.13% from A$0.039 on 2026-10-09 to A$0.041 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
PVE (issuer name unverified)
PVEPVE has a dividend/distribution announcement, creating a potential cash-return event. The amount, entitlement and funding are not established here; an ex-dividend price adjustment or insufficient residual cash could eliminate any apparent gain.
More details
Investment thesis
PVE has a dividend/distribution announcement, creating a potential cash-return event. The amount, entitlement and funding are not established here; an ex-dividend price adjustment or insufficient residual cash could eliminate any apparent gain.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Rectifier Technologies Ltd
RFTRectifier Technologies Ltd's reference price rose 9.09% from A$0.0055 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Rectifier Technologies Ltd's reference price rose 9.09% from A$0.0055 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Rand Mining Limited
RNDRand Mining Limited's reference price rose 9.76% from A$2.05 on 2026-10-09 to A$2.25 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Rand Mining Limited's reference price rose 9.76% from A$2.05 on 2026-10-09 to A$2.25 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Richmond Vanadium Technology Pty Ltd.
RVTRichmond Vanadium Technology Pty Ltd.'s reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Richmond Vanadium Technology Pty Ltd.'s reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Rubicon Water Limited
RWLRubicon Water Limited's reference price fell 6.15% from A$0.325 on 2026-10-09 to A$0.305 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Rubicon Water Limited's reference price fell 6.15% from A$0.325 on 2026-10-09 to A$0.305 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Sabre Resources Ltd
SBRSabre Resources Ltd's reference price fell 14.29% from A$0.007 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Sabre Resources Ltd's reference price fell 14.29% from A$0.007 on 2026-10-09 to A$0.006 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Star Minerals Ltd.
SMSStar Minerals Ltd.'s reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Star Minerals Ltd.'s reference price fell 5.13% from A$0.039 on 2026-10-09 to A$0.037 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Sentinel Metals Limited
SNMSentinel Metals Limited's reference price fell 20.20% from A$0.495 on 2026-10-09 to A$0.395 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Sentinel Metals Limited's reference price fell 20.20% from A$0.495 on 2026-10-09 to A$0.395 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Summerset Group Holdings Limited
SNZSummerset Group Holdings Limited's reference price rose 5.77% from A$5.2 on 2026-10-09 to A$5.5 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Summerset Group Holdings Limited's reference price rose 5.77% from A$5.2 on 2026-10-09 to A$5.5 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
SPC Global Holdings Ltd
SPGSPC Global Holdings Ltd's reference price fell 5.26% from A$0.076 on 2026-10-09 to A$0.072 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
SPC Global Holdings Ltd's reference price fell 5.26% from A$0.076 on 2026-10-09 to A$0.072 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
StepChange Holdings Ltd.
STHStepChange Holdings Ltd.'s reference price fell 11.11% from A$0.135 on 2026-10-09 to A$0.12 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
StepChange Holdings Ltd.'s reference price fell 11.11% from A$0.135 on 2026-10-09 to A$0.12 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Thorney Technologies Limited
TEKThorney Technologies Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Thorney Technologies Limited's reference price rose 5.00% from A$0.1 on 2026-10-09 to A$0.105 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
TerraCom Limited
TERTerraCom Limited's reference price rose 6.35% from A$0.063 on 2026-10-09 to A$0.067 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
TerraCom Limited's reference price rose 6.35% from A$0.063 on 2026-10-09 to A$0.067 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Titan Minerals Ltd
TTMTitan Minerals Ltd's reference price fell 6.36% from A$0.55 on 2026-10-09 to A$0.515 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Titan Minerals Ltd's reference price fell 6.36% from A$0.55 on 2026-10-09 to A$0.515 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Tivan Limited
TVNTivan Limited's reference price fell 7.89% from A$0.19 on 2026-10-09 to A$0.175 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Tivan Limited's reference price fell 7.89% from A$0.19 on 2026-10-09 to A$0.175 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
TZ Limited
TZLTZ Limited's reference price fell 15.38% from A$0.026 on 2026-10-09 to A$0.022 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
TZ Limited's reference price fell 15.38% from A$0.026 on 2026-10-09 to A$0.022 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Vulcan Steel Ltd.
VSLVulcan Steel Ltd.'s reference price fell 5.85% from A$5.47 on 2026-10-09 to A$5.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Vulcan Steel Ltd.'s reference price fell 5.85% from A$5.47 on 2026-10-09 to A$5.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
WT Financial Group Ltd.
WTLWT Financial Group Ltd.'s reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
WT Financial Group Ltd.'s reference price fell 6.25% from A$0.16 on 2026-10-09 to A$0.15 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Zimplats Holdings Limited
ZIMZimplats Holdings Limited's reference price fell 5.93% from A$15 on 2026-10-09 to A$14.11 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Zimplats Holdings Limited's reference price fell 5.93% from A$15 on 2026-10-09 to A$14.11 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Zip Co Ltd.
ZIPZip Co Ltd.'s reference price rose 5.56% from A$2.16 on 2026-10-09 to A$2.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Zip Co Ltd.'s reference price rose 5.56% from A$2.16 on 2026-10-09 to A$2.28 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Zinc of Ireland Limited
ZMIZinc of Ireland Limited's reference price rose 5.00% from A$0.02 on 2026-10-09 to A$0.021 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
More details
Investment thesis
Zinc of Ireland Limited's reference price rose 5.00% from A$0.02 on 2026-10-09 to A$0.021 on 2026-10-12. The move has no established business catalyst or recurring-earnings valuation case; further reversal or a corporate-action mismatch could erase the apparent opportunity.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
ACO-X.TO (issuer name unverified)
ACO-X.TOAn unconfirmed report for ACO-X.TO (issuer name unverified) describes merger with $EMA.TO at 0.865x shares+SpinCo. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for ACO-X.TO (issuer name unverified) describes merger with $EMA.TO at 0.865x shares+SpinCo. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Alimentation Couche-Tard
ATDAlimentation Couche-Tard has an Irving asset-acquisition headline that could change its operating footprint. Purchase terms, acquired cash flow and funding are unknown; overpayment, financing or integration costs could absorb any benefit.
More details
Investment thesis
Alimentation Couche-Tard has an Irving asset-acquisition headline that could change its operating footprint. Purchase terms, acquired cash flow and funding are unknown; overpayment, financing or integration costs could absorb any benefit.
Risk / thesis breaker
Unknown until primary body and financial security bridge read.
Aritzia Inc.
ATZAritzia has strong store and digital demand, with 34.5% comparable-sales growth supporting its retail expansion. The margin jump includes C$97.4m tariff refunds, however, while inventory and infrastructure spending rise. Harder comparisons, recurring compensation and distribution costs could leave shareholder cash well below headline earnings.
More details
Investment thesis
Aritzia has strong store and digital demand, with 34.5% comparable-sales growth supporting its retail expansion. The margin jump includes C$97.4m tariff refunds, however, while inventory and infrastructure spending rise. Harder comparisons, recurring compensation and distribution costs could leave shareholder cash well below headline earnings.
Risk / thesis breaker
Fashion/traffic reversal, inventory up36%, tariffs, harder comparisons and DC depreciation; adjusted earnings exclusions.
CU.TO (issuer name unverified)
CU.TOAn unconfirmed report for CU.TO (issuer name unverified) describes merger with $EMA.TO at 0.755x. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for CU.TO (issuer name unverified) describes merger with $EMA.TO at 0.755x. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Dye & Durham
DNDLegal/business software provider cutting costs against a heavy interest burden. Remaining C$6-8m savings leave the strict owner-cash sensitivity near breakeven after recurring SBC; covenant compliance, revenue retention and reinvestment can overwhelm the cuts.
More details
Investment thesis
Legal/business software provider cutting costs against a heavy interest burden. Remaining C$6-8m savings leave the strict owner-cash sensitivity near breakeven after recurring SBC; covenant compliance, revenue retention and reinvestment can overwhelm the cuts.
Risk / thesis breaker
Debt interest/covenants, reinvestment and transition cash, customer retention, savings realization and dilution.
Grupo Empresarial San José
GSJSan José has a €47.96m public-housing design/build contract over 48 months. It adds work but is small relative to group revenue, and customer advances and guarantees constrain headline cash. Cost overruns, payment delays or minority allocations could prevent the order from creating meaningful common-share value.
More details
Investment thesis
San José has a €47.96m public-housing design/build contract over 48 months. It adds work but is small relative to group revenue, and customer advances and guarantees constrain headline cash. Cost overruns, payment delays or minority allocations could prevent the order from creating meaningful common-share value.
Risk / thesis breaker
XML202 empty; procurement funding/payment and normalized forward economics unverified.
Dynagreen Environmental Protection Group
01330Dynagreen says its capex peak has passed and collections are stable, potentially improving cash available for dividends. The proposed 2027-29 payout floor is conditional, not a forward earnings forecast. Receivable collection, maintenance capex and convertible dilution could prevent the cash-return thesis from reaching H-share holders.
More details
Investment thesis
Dynagreen says its capex peak has passed and collections are stable, potentially improving cash available for dividends. The proposed 2027-29 payout floor is conditional, not a forward earnings forecast. Receivable collection, maintenance capex and convertible dilution could prevent the cash-return thesis from reaching H-share holders.
Risk / thesis breaker
Published network text interaction, not audio; convertible funding/conversion question partly unanswered; current H-share price and dilution unverified.
CLP Holdings Limited
0002No supported investment thesis is established for CLP Holdings from the unconfirmed Q3 event label. Earnings, cash generation and a concrete catalyst are unknown; adverse results, financing needs or an incorrect event identity could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for CLP Holdings from the unconfirmed Q3 event label. Earnings, cash generation and a concrete catalyst are unknown; adverse results, financing needs or an incorrect event identity could invalidate the setup.
Risk / thesis breaker
Unknown call identity/timezone and missing free transcript.
Computime Group Limited
00320Computime could improve profits through Mexico ramp absorption and a better controls and Salus mix. The analyst recovery case nearly triples profit, but sustainable cash is unproven, parent liquidity is minimal and the dated HK$0.44 quotation had no trades. Poor margin conversion or continuing development funding would break the recovery case.
More details
Investment thesis
Computime could improve profits through Mexico ramp absorption and a better controls and Salus mix. The analyst recovery case nearly triples profit, but sustainable cash is unproven, parent liquidity is minimal and the dated HK$0.44 quotation had no trades. Poor margin conversion or continuing development funding would break the recovery case.
Risk / thesis breaker
['Mexico ramp', 'Factoring and capitalized development', 'Parent cash', 'Zero trade liquidity']
Hengdeli Holdings Limited
3389.HKHengdeli proposes a HK$0.266-per-share capital return against a HK$0.32 dated reference price. Approval and solvency could release substantial cash, but the payout is not earnings or a guaranteed profit: residual business value, available parent cash and actual payment remain unresolved.
More details
Investment thesis
Hengdeli proposes a HK$0.266-per-share capital return against a HK$0.32 dated reference price. Approval and solvency could release substantial cash, but the payout is not earnings or a guaranteed profit: residual business value, available parent cash and actual payment remain unresolved.
Risk / thesis breaker
Nonwaivable approval/solvency conditions, ongoing residual losses, common-owner cash availability, NCI, taxes, postJune burn, ex-div price adjustment.
신라섬유 (English name unverified)
001000신라섬유신라섬유 is a small textile issue with a price-limit discovery, not an established earnings inflection. Property value, recurring profit and financing are unknown; weak cash or senior claims could erase the price-based opportunity.
More details
Investment thesis
신라섬유 is a small textile issue with a price-limit discovery, not an established earnings inflection. Property value, recurring profit and financing are unknown; weak cash or senior claims could erase the price-based opportunity.
Risk / thesis breaker
small textile issue; property/earnings/financing unreviewed.
알파칩스 (English name unverified)
117670알파칩스알파칩스 has a one-for-one bonus issue, which does not itself create economic value. Recurring earnings and cash remain unknown; weaker profits or dilution can overwhelm any price response to the share-count change.
More details
Investment thesis
알파칩스 has a one-for-one bonus issue, which does not itself create economic value. Recurring earnings and cash remain unknown; weaker profits or dilution can overwhelm any price response to the share-count change.
Risk / thesis breaker
1-for-1 issue does not create economic value; issuer earnings/FCF still unreviewed.
뉴인텍 (English name unverified)
012340뉴인텍뉴인텍 has electronic-component exposure, but orders, cash generation and capital survival are unproven. A price response without funded demand or sustainable margins could reverse, and financing claims could dominate common value.
More details
Investment thesis
뉴인텍 has electronic-component exposure, but orders, cash generation and capital survival are unproven. A price response without funded demand or sustainable margins could reverse, and financing claims could dominate common value.
Risk / thesis breaker
electronic components; capital survival/orders/cash unreviewed.
BGF에코머티리얼즈 (English name unverified)
126600BGF에코머티리얼즈 has a funded tender deposit and a new buyback trust, providing concrete shareholder-return mechanisms. Full acceptance at the captured price is only a gross sensitivity; proration, taxes and access can reduce proceeds. A related-party asset transfer is not an external group-wide windfall.
More details
Investment thesis
BGF에코머티리얼즈 has a funded tender deposit and a new buyback trust, providing concrete shareholder-return mechanisms. Full acceptance at the captured price is only a gross sensitivity; proration, taxes and access can reduce proceeds. A related-party asset transfer is not an external group-wide windfall.
Risk / thesis breaker
Proration; deemed-dividend/withholding disclosure; NH account and citizenship/residency/IBKR eligibility; related-party fairness; lost KNW earnings and fresh-share repurchase execution.
나래나노텍 (English name unverified)
137080나래나노텍 plans repurchases for cancellation, which could reduce shares if executed and retained. The mandate itself is not earnings or cash paid to every holder; execution, compensation and recurring profit determine whether the per-share benefit survives.
More details
Investment thesis
나래나노텍 plans repurchases for cancellation, which could reduce shares if executed and retained. The mandate itself is not earnings or cash paid to every holder; execution, compensation and recurring profit determine whether the per-share benefit survives.
Risk / thesis breaker
Order-cycle deterioration; execution/liquidity and unverified future owner earnings; no announcement-to-profit substitution.
메디앙스 (English name unverified)
014100메디앙스 has share-purchase mechanics, but employee delivery can restore economic shares and create compensation costs. The apparent capital-return percentage is not permanent shareholder value; dilution, expenses and weak recurring earnings could invalidate it.
More details
Investment thesis
메디앙스 has share-purchase mechanics, but employee delivery can restore economic shares and create compensation costs. The apparent capital-return percentage is not permanent shareholder value; dilution, expenses and weak recurring earnings could invalidate it.
Risk / thesis breaker
Employee compensation/reissue; no cancellation commitment in the reviewed filing; weak liquidity and unsupported normalized economics.
대교 (English name unverified)
019685대교대교 has a treasury-share disposal-result filing. The transaction could alter capital and ownership, but proceeds, compensation costs and recurring earnings are unknown; dilution or poor use of cash could defeat any shareholder benefit.
More details
Investment thesis
대교 has a treasury-share disposal-result filing. The transaction could alter capital and ownership, but proceeds, compensation costs and recurring earnings are unknown; dilution or poor use of cash could defeat any shareholder benefit.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
뱅크웨어글로벌 (English name unverified)
199480뱅크웨어글로벌 has a visible delivery backlog with 30% advances and further payments at acceptance. Advances can finance delivery but are not profit, and revenue spans 2026-27. Cost overruns, delayed acceptance or low margins could prevent the backlog from becoming common-share cash.
More details
Investment thesis
뱅크웨어글로벌 has a visible delivery backlog with 30% advances and further payments at acceptance. Advances can finance delivery but are not profit, and revenue spans 2026-27. Cost overruns, delayed acceptance or low margins could prevent the backlog from becoming common-share cash.
Risk / thesis breaker
Bank/customer concentration; fixed-scope execution over14months; design/final acceptance and delay provisions; cash timing.
휴마시스 (English name unverified)
205470휴마시스휴마시스 has a diagnostic-demand theme, but actual orders and recurring margins are unknown. Paid demand could matter, while funding needs or a short-lived thematic spike could invalidate the setup.
More details
Investment thesis
휴마시스 has a diagnostic-demand theme, but actual orders and recurring margins are unknown. Paid demand could matter, while funding needs or a short-lived thematic spike could invalidate the setup.
Risk / thesis breaker
diagnostic theme; actual orders/recurring margins/funding unreviewed.
본느 (English name unverified)
226340본느본느 has cosmetics exposure and touched a price limit before a negative close. No operating catalyst or recurring cash case is established; weak demand, funding or reversal could erase the apparent opportunity.
More details
Investment thesis
본느 has cosmetics exposure and touched a price limit before a negative close. No operating catalyst or recurring cash case is established; weak demand, funding or reversal could erase the apparent opportunity.
Risk / thesis breaker
cosmetics; touch then negative close, actual catalyst/earnings/cash unreviewed.
유진테크놀로지 (English name unverified)
240600유진테크놀로지유진테크놀로지 has battery-production equipment exposure, but order margins, working capital and debt are unknown. Conversion of orders into paid profitable deliveries could matter; cost overruns or financing could absorb the benefit.
More details
Investment thesis
유진테크놀로지 has battery-production equipment exposure, but order margins, working capital and debt are unknown. Conversion of orders into paid profitable deliveries could matter; cost overruns or financing could absorb the benefit.
Risk / thesis breaker
battery-production equipment; order margin/WC/debt unreviewed.
국제약품 (English name unverified)
002720국제약품국제약품 has a pharmaceutical-demand theme without a verified company-specific profit catalyst. Sustainable earnings and cash are unknown; unfulfilled demand, funding or price reversal could invalidate the setup.
More details
Investment thesis
국제약품 has a pharmaceutical-demand theme without a verified company-specific profit catalyst. Sustainable earnings and cash are unknown; unfulfilled demand, funding or price reversal could invalidate the setup.
Risk / thesis breaker
pharmaceutical demand theme; exact catalyst/earnings/cash unreviewed.
SUN&L
002820SUN&L has asset-sale and cancellation claims, potentially affecting capital returns. Actual proceeds, debt and core earnings are unknown; senior claims, failed execution or poor reinvestment could absorb any benefit.
More details
Investment thesis
SUN&L has asset-sale and cancellation claims, potentially affecting capital returns. Actual proceeds, debt and core earnings are unknown; senior claims, failed execution or poor reinvestment could absorb any benefit.
Risk / thesis breaker
asset-sale/cancellation claims; actual cash proceeds/debt/core business unreviewed.
플리토 (English name unverified)
300080플리토 has near-term solution and SI delivery payments, but the license/labor mix is undisclosed and not proven recurring SaaS revenue. A separate earlier purchase order was cut materially. Delivery costs, customer concentration or further amendments could absorb the apparent growth.
More details
Investment thesis
플리토 has near-term solution and SI delivery payments, but the license/labor mix is undisclosed and not proven recurring SaaS revenue. A separate earlier purchase order was cut materially. Delivery costs, customer concentration or further amendments could absorb the apparent growth.
Risk / thesis breaker
Customer secrecy; cancellation/amendment and labor delivery; unrelated old PO collection still pendingFeb9,2027.
HLB글로벌 (English name unverified)
003580HLB글로벌HLB글로벌 has group-restructuring exposure, but merger, convertible and attributable recurring earnings terms are unresolved. The transaction could alter common claims, while dilution or weak underlying cash could dominate the outcome.
More details
Investment thesis
HLB글로벌 has group-restructuring exposure, but merger, convertible and attributable recurring earnings terms are unresolved. The transaction could alter common claims, while dilution or weak underlying cash could dominate the outcome.
Risk / thesis breaker
group restructuring; merger/CB and recurring attributable earnings unreviewed.
SAMKEE ENERGY SOLUTIONS Co.,LTD
419050삼기에너지솔루션즈Samkee Energy Solutions grew revenue 73% while operating profit fell 12%, and owner cash was negative KRW6.062bn. Sales growth is not recurring cheapness; margins, other income, minorities and funding could prevent it reaching shareholders.
More details
Investment thesis
Samkee Energy Solutions grew revenue 73% while operating profit fell 12%, and owner cash was negative KRW6.062bn. Sales growth is not recurring cheapness; margins, other income, minorities and funding could prevent it reaching shareholders.
Risk / thesis breaker
revenue +73%, OP -12%; owner cash -6.062bn; historical diluted repetition12.97x, not forward. IR/other-income/NCI gates.
SAMG ENTERTAINMENT CO.,LTD
419530SAMG엔터SAMG Entertainment has an IP and content-slate opportunity, but H1 operating profit fell 49% and owner cash was negative KRW11.051bn. Preference claims, cash conversion and taxes could prevent the franchise from producing common-share value.
More details
Investment thesis
SAMG Entertainment has an IP and content-slate opportunity, but H1 operating profit fell 49% and owner cash was negative KRW11.051bn. Preference claims, cash conversion and taxes could prevent the franchise from producing common-share value.
Risk / thesis breaker
H1 OP -49%; owner cash -11.051bn; historical repetition23.76x, not forward. IP/slate/preference/tax gates.
HLB파나진 (English name unverified)
046210HLB파나진HLB파나진 has PNA diagnostic exposure, but paid orders and recurring margins are unproven. Commercial uptake could matter; funding, dilution or weak realized demand could invalidate the theme.
More details
Investment thesis
HLB파나진 has PNA diagnostic exposure, but paid orders and recurring margins are unproven. Commercial uptake could matter; funding, dilution or weak realized demand could invalidate the theme.
Risk / thesis breaker
PNA diagnostics; paid orders/recurring margins/dilution unreviewed.
천일고속 (English name unverified)
000650천일고속천일고속 has terminal-asset exposure, but historical losses and unresolved ownership and project distributions prevent a cash-value conclusion. Creditor claims, funding or a lack of realized distributions could break the asset thesis.
More details
Investment thesis
천일고속 has terminal-asset exposure, but historical losses and unresolved ownership and project distributions prevent a cash-value conclusion. Creditor claims, funding or a lack of realized distributions could break the asset thesis.
Risk / thesis breaker
H1 EPS-2172; terminal book32.027bn versus315.143bn cap; ownership/project distributions unresolved.
DONGYANG EXPRESS CORP.
084670동양고속Dongyang Express has a small terminal stake and historical losses, not proven shareholder recovery. Property title, debt and distributions remain unresolved; senior claims or poor realization could absorb the asset value.
More details
Investment thesis
Dongyang Express has a small terminal stake and historical losses, not proven shareholder recovery. Property title, debt and distributions remain unresolved; senior claims or poor realization could absorb the asset value.
Risk / thesis breaker
terminal stake0.16%; H1 EPS-914; property/title/debt waterfall unresolved.
NEXT.OL (issuer name unverified)
NEXT.OLAn unconfirmed report for NEXT.OL (issuer name unverified) describes planned bankruptcy filing. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for NEXT.OL (issuer name unverified) describes planned bankruptcy filing. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Glintt Global
GLINTGlintt has a €667,575, 24-month contract, not a €66.76m award. Consortium allocation is unknown and the order is small relative to revenue. Wage inflation, capitalized costs and customer-funded cash could overwhelm its profit contribution, so the award alone does not support a rerating.
More details
Investment thesis
Glintt has a €667,575, 24-month contract, not a €66.76m award. Consortium allocation is unknown and the order is small relative to revenue. Wage inflation, capitalized costs and customer-funded cash could overwhelm its profit contribution, so the award alone does not support a rerating.
Risk / thesis breaker
XML202 empty; economic own allocation and current price unknown.
ORX.ST (issuer name unverified)
ORX.STAn unconfirmed report for ORX.ST (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for ORX.ST (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
LDROBOT
01236LDROBOT has an announced acquisition of SABO-Maschinenfabrik. Consideration, acquired profit and funding are unknown; overpayment, integration costs or dilution could absorb any operating benefit.
More details
Investment thesis
LDROBOT has an announced acquisition of SABO-Maschinenfabrik. Consideration, acquired profit and funding are unknown; overpayment, integration costs or dilution could absorb any operating benefit.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
ESWIN COMPUTING
01256ESWIN Computing has final offer-price and allotment news, but no supported earnings or cash-flow valuation case is established. Offering terms, dilution and cash needs determine whether the listing creates common-share value.
More details
Investment thesis
ESWIN Computing has final offer-price and allotment news, but no supported earnings or cash-flow valuation case is established. Offering terms, dilution and cash needs determine whether the listing creates common-share value.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
VPOWER GROUP
01608VPOWER has an update on proposed restructuring, which could alter debt and common claims. The completed terms and recurring business economics are unknown; creditor priority or dilution could consume any recovery.
More details
Investment thesis
VPOWER has an update on proposed restructuring, which could alter debt and common claims. The completed terms and recurring business economics are unknown; creditor priority or dilution could consume any recovery.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Dongyue Group Limited
00189Dongyue has a sharp nine-month profit inflection at its organosilicone subsidiary. The catalyst is real subsidiary recovery, but parent ownership, minority claims, cycle prices and recurring adjustments are not bridged to common earnings; no forward P/E is established.
More details
Investment thesis
Dongyue has a sharp nine-month profit inflection at its organosilicone subsidiary. The catalyst is real subsidiary recovery, but parent ownership, minority claims, cycle prices and recurring adjustments are not bridged to common earnings; no forward P/E is established.
Risk / thesis breaker
['Cyclical silicone prices', 'Unaudited management estimate', 'Minority ownership', 'Nonrecurring adjustment definition', 'Parent financial bridge incomplete']
Ritamix Global Limited
01936Ritamix declares a HK$0.29 capital distribution,10% of its HK$2.90 dated close, by reallocating abandoned plant-expansion IPO funds. Dividend entitlement is the catalyst, but ex-dividend adjustment, parent cash and control-offer deductions prevent treating yield as total return.
More details
Investment thesis
Ritamix declares a HK$0.29 capital distribution,10% of its HK$2.90 dated close, by reallocating abandoned plant-expansion IPO funds. Dividend entitlement is the catalyst, but ex-dividend adjustment, parent cash and control-offer deductions prevent treating yield as total return.
Risk / thesis breaker
['Ex-dividend price adjustment', 'Control-sale offer terms and funding', 'Abandoned expansion', 'Distributable parent cash unverified']
PLUS GP HOLDING
02486PLUS GP has connected acquisitions of subsidiary equity that could change its assets and income. Purchase price, ownership and financing are unknown; unfavorable related-party terms could transfer value away from common holders.
More details
Investment thesis
PLUS GP has connected acquisitions of subsidiary equity that could change its assets and income. Purchase price, ownership and financing are unknown; unfavorable related-party terms could transfer value away from common holders.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Xinhua News Media Holdings Limited
00309Xinhua corrects the record of a153m-share debt settlement that completed in May, not fresh October cash. Separate placing and court/validation deadlines remain unresolved; duplicate-counted dilution, winding-up risk and stale price evidence prevent a cash-value conclusion.
More details
Investment thesis
Xinhua corrects the record of a153m-share debt settlement that completed in May, not fresh October cash. Separate placing and court/validation deadlines remain unresolved; duplicate-counted dilution, winding-up risk and stale price evidence prevent a cash-value conclusion.
Risk / thesis breaker
['Winding-up/validation conditions inherited', 'Duplicate-counted shares', 'No new cash from debt settlement', 'Stale quote']
CNBM
03323CNBM has a subscription and deemed-disposal transaction involving Sinoma Science & Technology. Parent ownership, consideration and earnings allocation are unknown; dilution or connected-party terms could absorb any benefit.
More details
Investment thesis
CNBM has a subscription and deemed-disposal transaction involving Sinoma Science & Technology. Parent ownership, consideration and earnings allocation are unknown; dilution or connected-party terms could absorb any benefit.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
FORGAME
00484Forgame has acquisitions of listed securities, but no supported link to recurring operating earnings. Portfolio losses, financing costs or related claims could undermine common-share value; a securities purchase alone is not a valuation catalyst.
More details
Investment thesis
Forgame has acquisitions of listed securities, but no supported link to recurring operating earnings. Portfolio losses, financing costs or related claims could undermine common-share value; a securities purchase alone is not a valuation catalyst.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
FAST RETAIL-DRS
06288Fast Retailing depositary securities have annual-results and trading-resumption news. Recurring earnings, cash conversion and the depositary unit bridge remain unknown; weak results or incorrect rights and price interpretation could invalidate the setup.
More details
Investment thesis
Fast Retailing depositary securities have annual-results and trading-resumption news. Recurring earnings, cash conversion and the depositary unit bridge remain unknown; weak results or incorrect rights and price interpretation could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Fineland Living Services Group Limited
09978Fineland has an unconditional HK$0.14 mandatory offer after a controlling-stake purchase. Its HK$2.83 dated market close is far above the offer, so this is not positive cash arbitrage; subscription/warrant dilution, control and public float remain the risks.
More details
Investment thesis
Fineland has an unconditional HK$0.14 mandatory offer after a controlling-stake purchase. Its HK$2.83 dated market close is far above the offer, so this is not positive cash arbitrage; subscription/warrant dilution, control and public float remain the risks.
Risk / thesis breaker
['Offer materially below market', 'Subscription/warrant dilution', 'Public-float and control risks']
Fortress Minerals Limited
OAJFortress is an iron-ore producer with a low historical annualized earnings diagnostic, not certified forward cheapness. Debt and leases exceed cash and contracted capex remains; realized ore prices, replacement spending, taxes, dilution and account access determine owner returns.
More details
Investment thesis
Fortress is an iron-ore producer with a low historical annualized earnings diagnostic, not certified forward cheapness. Debt and leases exceed cash and contracted capex remains; realized ore prices, replacement spending, taxes, dilution and account access determine owner returns.
Risk / thesis breaker
Iron ore ASP/volume and dry/wet conversion; capex commitmentUSD4.568m; no maintenance-growth split or FY1 funding/share count confirmed.
恆大 (English name unverified)
1325恆大恆大 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
恆大 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
大山 (English name unverified)
1615大山大山 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
大山 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
中纖 (English name unverified)
1718中纖中纖 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
中纖 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
隴華 (English name unverified)
2424隴華隴華 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
隴華 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
藝舍-KY (English name unverified)
2724藝舍-KY藝舍-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
藝舍-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
聯亞 (English name unverified)
3081聯亞聯亞 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
聯亞 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
千如 (English name unverified)
3236千如千如 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
千如 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
台星科 (English name unverified)
3265台星科台星科 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
台星科 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
熱映 (English name unverified)
3373熱映熱映 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
熱映 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
展達 (English name unverified)
3447展達展達 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
展達 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
光頡 (English name unverified)
3624光頡光頡 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
光頡 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
康聯訊 (English name unverified)
3672康聯訊康聯訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
康聯訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
天良 (English name unverified)
4127天良天良 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
天良 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
瑞基 (English name unverified)
4171瑞基瑞基 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
瑞基 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
永笙-KY (English name unverified)
4178永笙-KY永笙-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
永笙-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
萬在 (English name unverified)
4543萬在萬在 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
萬在 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
聯光通 (English name unverified)
4903聯光通聯光通 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
聯光通 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
前鼎 (English name unverified)
4908前鼎前鼎 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
前鼎 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
欣厚-KY (English name unverified)
4924欣厚-KY欣厚-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
欣厚-KY has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
太極 (English name unverified)
4934太極太極 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
太極 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
乙盛-KY (English name unverified)
5243乙盛-KY乙盛-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
乙盛-KY has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
同協 (English name unverified)
5460同協同協 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
同協 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
合邦 (English name unverified)
6103合邦合邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
合邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
頎邦 (English name unverified)
6147頎邦頎邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
頎邦 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
高僑 (English name unverified)
6234高僑高僑 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
高僑 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
點序 (English name unverified)
6485點序點序 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
點序 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
南六 (English name unverified)
6504南六南六 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
南六 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
金萬林-創 (English name unverified)
6645金萬林-創金萬林-創 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
金萬林-創 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
智聯服務 (English name unverified)
6751智聯服務智聯服務 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
智聯服務 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
宏碁資訊 (English name unverified)
6811宏碁資訊宏碁資訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
宏碁資訊 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
金山電 (English name unverified)
8042金山電金山電 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
金山電 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
越峰 (English name unverified)
8121越峰越峰 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
越峰 has a historical limit-up or limit-touch observation from 2026-10-07, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
美德醫療-DR (English name unverified)
9103美德醫療-DR美德醫療-DR has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
美德醫療-DR has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
康那香 (English name unverified)
9919康那香康那香 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
More details
Investment thesis
康那香 has a historical limit-up or limit-touch observation from 2026-10-08, not an established cash-profit inflection. Business economics, a concrete catalyst and recurring earnings are unknown. A locked quotation is not an executable entry; price reversal or a corporate-action mismatch could invalidate the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
1SN.L (issuer name unverified)
1SN.LAn unconfirmed report for 1SN.L (issuer name unverified) describes indicative offer from $MLX.AX at 15p. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for 1SN.L (issuer name unverified) describes indicative offer from $MLX.AX at 15p. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Colefax Group
CFX.LAn unconfirmed report for Colefax Group describes tender offer for 12% at min 1,350p/105% of 5-day average. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for Colefax Group describes tender offer for 12% at min 1,350p/105% of 5-day average. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
KMR.L (issuer name unverified)
KMR.LAn unconfirmed report for KMR.L (issuer name unverified) describes non-binding offer from International Resources Holdings. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for KMR.L (issuer name unverified) describes non-binding offer from International Resources Holdings. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
LDG.L (issuer name unverified)
LDG.LAn unconfirmed report for LDG.L (issuer name unverified) describes revised offer from DBAY at 20p (rejected). This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for LDG.L (issuer name unverified) describes revised offer from DBAY at 20p (rejected). This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
PNN.L (issuer name unverified)
PNN.LAn unconfirmed report for PNN.L (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for PNN.L (issuer name unverified) describes rights issue. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Atrium Ljungberg
Ticker unverifiedAtrium Ljungberg Q3 2026 shows mixed results. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Atrium Ljungberg Q3 2026 shows mixed results. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
BEI.SI (issuer name unverified)
BEI.SIAn unconfirmed report for BEI.SI (issuer name unverified) describes partial offer from chairman for 25% at S$0.75. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for BEI.SI (issuer name unverified) describes partial offer from chairman for 25% at S$0.75. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
BMPS.MI (issuer name unverified)
BMPS.MIAn unconfirmed report for BMPS.MI (issuer name unverified) describes price increased by $ISPM.I to €1.25+1.6x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for BMPS.MI (issuer name unverified) describes price increased by $ISPM.I to €1.25+1.6x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Charlton Aria Acquisition
CHARAn unconfirmed report for Charlton Aria Acquisition describes SPAC merger with KQC Quantum. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for Charlton Aria Acquisition describes SPAC merger with KQC Quantum. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Caribou Biosciences
CRBUAn unconfirmed report for Caribou Biosciences describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for Caribou Biosciences describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
CVKD (issuer name unverified)
CVKDAn unconfirmed report for CVKD (issuer name unverified) describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for CVKD (issuer name unverified) describes strategic review. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Camil
Ticker unverifiedCamil posts mixed Q2 2026 results as rice prices recover. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Camil posts mixed Q2 2026 results as rice prices recover. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Canara Robeco
Ticker unverifiedCanara Robeco posts strong Q2 2027 profit growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Canara Robeco posts strong Q2 2027 profit growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Delta Air Lines
Ticker unverifiedDelta Air Lines posts Q3 2026 revenue beat, EPS miss. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Delta Air Lines posts Q3 2026 revenue beat, EPS miss. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
FCG.PS (issuer name unverified)
FCG.PSAn unconfirmed report for FCG.PS (issuer name unverified) describes take-private by parent Figaro Coffee Systems for ₱0.82. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for FCG.PS (issuer name unverified) describes take-private by parent Figaro Coffee Systems for ₱0.82. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Horizon Aircraft
Ticker unverifiedHorizon Aircraft rises on X7 progress in Q1 2027. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Horizon Aircraft rises on X7 progress in Q1 2027. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Prabos plus
Ticker unverifiedPrabos plus has a CZK4.35m, four-year framework that could generate orders, not firm funded revenue. Actual call-offs, margins and public-share exposure are unknown; nonexecution or low profitability could leave no meaningful common-share benefit.
More details
Investment thesis
Prabos plus has a CZK4.35m, four-year framework that could generate orders, not firm funded revenue. Actual call-offs, margins and public-share exposure are unknown; nonexecution or low profitability could leave no meaningful common-share benefit.
Risk / thesis breaker
Framework utilization, listed eligibility and primary financial underwriting deferred.
Sevenet
Ticker unverifiedSevenet has a PLN4.78m non-framework contract, but its duration and shareholder economics are unknown. Delivery margins, collection and funding determine whether the order adds common-share cash; contract value is not recurring profit.
More details
Investment thesis
Sevenet has a PLN4.78m non-framework contract, but its duration and shareholder economics are unknown. Delivery margins, collection and funding determine whether the order adds common-share cash; contract value is not recurring profit.
Risk / thesis breaker
Reduced budget deferred primary financial underwriting and full notice.
Triolab AB / potential AddLife parent
Ticker unverifiedTriolab is named for SEK92.576m blood-gas and oximetry contracts, but its listed-parent exposure is unverified. Contract margins and actual ownership determine any common-share benefit; incorrect parent attribution or delivery costs could invalidate the setup.
More details
Investment thesis
Triolab is named for SEK92.576m blood-gas and oximetry contracts, but its listed-parent exposure is unverified. Contract margins and actual ownership determine any common-share benefit; incorrect parent attribution or delivery costs could invalidate the setup.
Risk / thesis breaker
Reduced budget deferred full notice, parent, issuer filings and price.
CSLM Digital Asset Acquisition III
KOYNAn unconfirmed report for CSLM Digital Asset Acquisition III describes SPAC merger with First Digital. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for CSLM Digital Asset Acquisition III describes SPAC merger with First Digital. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
Poonawalla Fincorp
Ticker unverifiedPoonawalla Fincorp posts strong Q2 2026 growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Poonawalla Fincorp posts strong Q2 2026 growth. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Recordati
REC.MIAn unconfirmed report for Recordati describes price increase by CVC consortium to €53. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for Recordati describes price increase by CVC consortium to €53. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
RXO, Inc. Common Stock
RXOAn unconfirmed report for RXO, Inc. Common Stock describes acquisition by $CHRW for $17.25+0.0856x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
More details
Investment thesis
An unconfirmed report for RXO, Inc. Common Stock describes acquisition by $CHRW for $17.25+0.0856x shares. This is not proof of a completed transaction or common-share profit. Binding terms, funding and senior claims are unknown; noncompletion, dilution or adverse terms could defeat the setup.
Risk / thesis breaker
Cash conversion, financing and exact rights are unverified.
SSP Group
Ticker unverifiedSSP Group shares fall as cash flow outlook softens in Q4 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
SSP Group shares fall as cash flow outlook softens in Q4 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Seven & i Holdings
Ticker unverifiedSeven & i Holdings tops Q2 2026 forecasts. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Seven & i Holdings tops Q2 2026 forecasts. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Tryg
Ticker unverifiedTryg Q3 2026 profit strength lifts shares 3.8%. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Tryg Q3 2026 profit strength lifts shares 3.8%. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
Volution Group
Ticker unverifiedVolution Group posts strong FY 2026, shares steady in H2 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
More details
Investment thesis
Volution Group posts strong FY 2026, shares steady in H2 2026. This is a headline-only setup: recurring earnings, owner cash and valuation are unknown, and a weak cash or financing bridge could invalidate the apparent result.
Risk / thesis breaker
Actual recurring economics, cash/financing and event identity unknown
AI OKTO CORP.
AIOKAiok received two LPG carriers andUS$45m cash in Toro spin-off, alongside aUS$25m senior convertible preferred claim held byToro. Standalone fixtures/cash and capital terms are the catalysts; common dilution, senior conversion, liabilities and cash restrictions are not underwritten.
More details
Investment thesis
Aiok received two LPG carriers andUS$45m cash in Toro spin-off, alongside aUS$25m senior convertible preferred claim held byToro. Standalone fixtures/cash and capital terms are the catalysts; common dilution, senior conversion, liabilities and cash restrictions are not underwritten.
Risk / thesis breaker
Preferred/control, dilution, liability and cash restrictions
ANGIODYNAMICS INC
ANGONo supported investment thesis is established for ANGIODYNAMICS INC yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for ANGIODYNAMICS INC yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
Black Hills Corporation
BKHBlack Hills has signed long-term agreements to serve Google, with management expecting project earnings to begin in 2027 and reach about $150m in 2030. The opportunity depends on funding a $1.8bn build without excessive common dilution. Construction, financing or regulatory costs could absorb the distant earnings benefit.
More details
Investment thesis
Black Hills has signed long-term agreements to serve Google, with management expecting project earnings to begin in 2027 and reach about $150m in 2030. The opportunity depends on funding a $1.8bn build without excessive common dilution. Construction, financing or regulatory costs could absorb the distant earnings benefit.
Risk / thesis breaker
Financing, dilution, construction, merger/claims allocation
Commerce.com, Inc.
CMRCCommerce.com sells commerce software. Its announced cost reset could improve cash generation as savings arrive in 2027, but customer contraction, recurring stock compensation and software investment can absorb the benefit. The updated cash bridge remains conditional, and unverified note settlement or dilution is the principal thesis-breaker.
More details
Investment thesis
Commerce.com sells commerce software. Its announced cost reset could improve cash generation as savings arrive in 2027, but customer contraction, recurring stock compensation and software investment can absorb the benefit. The updated cash bridge remains conditional, and unverified note settlement or dilution is the principal thesis-breaker.
Risk / thesis breaker
['Grossprofit/reinvestment offsets', 'Planexpense8.5-26.3m notcashschedule', 'Unverifiednote/couponsettlement', 'Currentdilution', '150m2028principal/refinancing', 'Noexecutabledepth']
Crescent Energy Co
CRGYNo supported investment thesis is established for Crescent Energy Co yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for Crescent Energy Co yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
HELEN OF TROY LTD
HELENo supported investment thesis is established for HELEN OF TROY LTD yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for HELEN OF TROY LTD yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
Main Street Capital CORP
MAINNo supported investment thesis is established for Main Street Capital CORP yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for Main Street Capital CORP yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
MSC INCOME FUND, INC.
MSIFNo supported investment thesis is established for MSC INCOME FUND, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for MSC INCOME FUND, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
Oil-Dri Corporation of America
ODCOil-Dri has strong co-pack demand and historical cash generation, offering a route to better operating cash. Annual operating income was nevertheless flat, and a legal settlement and Amlan quarter rebound cannot establish recurring growth. Weak underlying margins, working-capital needs or higher capex could defeat the setup.
More details
Investment thesis
Oil-Dri has strong co-pack demand and historical cash generation, offering a route to better operating cash. Annual operating income was nevertheless flat, and a legal settlement and Amlan quarter rebound cannot establish recurring growth. Weak underlying margins, working-capital needs or higher capex could defeat the setup.
Risk / thesis breaker
Freight inflation, retail concentration/promotions, Amlan rebound, higher reinvestment.
Resources Connection, Inc.
RGPResources Connection is attempting to rebuild consulting demand through sales hiring and utilization improvements. Management expects hiring benefits mainly in the last two fiscal quarters; continuing revenue contraction and negative adjusted EBITDA could consume the recovery before it reaches common shareholders.
More details
Investment thesis
Resources Connection is attempting to rebuild consulting demand through sales hiring and utilization improvements. Management expects hiring benefits mainly in the last two fiscal quarters; continuing revenue contraction and negative adjusted EBITDA could consume the recovery before it reaches common shareholders.
Risk / thesis breaker
Pre-call USD equity cap, exact call clock, IBKR line/access and analyst completion unknown.
RCI HOSPITALITY HOLDINGS, INC.
RICKNo supported investment thesis is established for RCI HOSPITALITY HOLDINGS, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for RCI HOSPITALITY HOLDINGS, INC. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
Tilray Brands, Inc.
TLRYNo supported investment thesis is established for Tilray Brands, Inc. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
More details
Investment thesis
No supported investment thesis is established for Tilray Brands, Inc. yet. An earnings-results disclosure is the only signal; recurring profit, cash generation and valuation are unknown, so adverse operating results or senior financing claims could invalidate the setup.
Risk / thesis breaker
Unknown recurring economics, senior claims, dilution and execution
EBR Systems Inc
EBREBR sells WiSE wireless cardiac pacing; Q3 implants and preliminary revenue fell despite more activated accounts. Repeat usage, site PMA and cash/debt runway are the catalysts, but losses, cash burn and additional recapitalization are the breakers; the source CDI line prohibits US persons except QIB.
More details
Investment thesis
EBR sells WiSE wireless cardiac pacing; Q3 implants and preliminary revenue fell despite more activated accounts. Repeat usage, site PMA and cash/debt runway are the catalysts, but losses, cash burn and additional recapitalization are the breakers; the source CDI line prohibits US persons except QIB.
Risk / thesis breaker
Source-reviewed ASX CDI terms prohibit US persons except QIB; ordinary individual access not established. Underlying common is not substituted. ['unsupported FY1/FY2 and matched peers', 'official adjusted CSPA not verified', 'current gross capital/cash and exact account permission unresolved']
Xin Yuan Enterprises Group Limited
01748Xin Yuan has a possible HK$2.21 cash offer conditional on resuming its suspended shares before October30. The old HK$1.76 trade is not an available entry; resumption, greater-than50% acceptance, financing and adverse-change terms can break the event.
More details
Investment thesis
Xin Yuan has a possible HK$2.21 cash offer conditional on resuming its suspended shares before October30. The old HK$1.76 trade is not an available entry; resumption, greater-than50% acceptance, financing and adverse-change terms can break the event.
Risk / thesis breaker
Dated source establishes suspension; current resumption/executable entry not verified. ['Suspension', 'Resumption/offer may fail', 'Acceptance condition', 'MAC', 'No executable price']